×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Virtual Congress 2020
Final Programme PDF
Advanced Search
14.09.2020
15.09.2020
17.09.2020
18.09.2020
19.09.2020
20.09.2020
21.09.2020
22.09.2020
23.09.2020
12.10.2020
13.10.2020
14.10.2020
15.10.2020
16.10.2020
17.10.2020
18.10.2020
Educational session
Keynote lecture
Patient advocacy session
Special symposium
Young Oncologist session
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
Channel 1
12:10(1h 20m)
Are we ready for another big step in kidney and bladder cancer?
16:10(1h 20m)
Breakthroughs in immunotherapy for non-metastatic NSCLC
13:45(30m)
Linking genetic alterations to dependencies for new cancer therapeutics
10:30(1h 20m)
Recent updates in treatment strategies
14:30(1h 20m)
Treatment of upper GI tumours in the time of precision oncology
Channel 2
14:30(1h 20m)
Biggest challenges facing young oncologists in 2030: How to address the next generation of anticancer treatments
10:30(1h 20m)
Blood-brain barrier
16:10(1h 20m)
Unlocking precision medicine for metastatic prostate cancer
12:10(1h 20m)
What to do with patients who attend appointments with a next generation sequencing (NGS) platform dataset
Channel 3
14:30(1h 20m)
Abscopal and anenestic effect: Local immunotherapies with systemic potential
10:30(1h 20m)
Checkpoint inhibitors and beyond in gynaecological cancers
16:10(1h 20m)
Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
12:10(1h 20m)
Targeting DNA damage response pathways in cancer
Channel 4
10:30(1h 20m)
Applications of artificial intelligence (AI) in oncology drug development
12:10(1h 20m)
Management of soft tissue sarcomas in 2020: Digital developments and tempting treatments
16:10(1h 20m)
Preclinical models for unanswered clinical questions
14:30(1h 20m)
The microenvironment of cancer
Channel 5
16:10(1h 20m)
How patient advocates can improve equal access to care and services across Europe and beyond: Concrete examples of success stories
14:30(1h 20m)
How to implement screening for lung cancer
10:30(1h 20m)
Peptide Receptor Radionuclide Therapy (PRRT) integration with other therapies
12:10(1h 20m)
The cancer journey: The importance of getting the right physical and mental support
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events